| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VBI Vaccines Inc/BC | Director | Common Shares, no par value per share | 1,043,292 | $1,721,432 | $1.65 | 10 Jul 2023 | Indirect |
| Homology Medicines, Inc. | Director | Option (Right to Buy) | 23,000 | $308,660 | $13.42 | 14 Jun 2023 | Direct |
| VBI Vaccines Inc/BC | Director | Common Shares, no par value per share | 2,814 | $4,643 | $1.65 | 10 Jul 2023 | Direct |
| VBI Vaccines Inc/BC | Director | Warrant (right to buy) | 609,090 | 10 Jul 2023 | Indirect | ||
| VBI Vaccines Inc/BC | Director | Option (Right to Buy Common Shares) | 52,500 | 27 Jul 2023 | Direct | ||
| Codiak BioSciences, Inc. | Director | Common Stock | 8,750 | 16 Feb 2023 | Direct | ||
| Codiak BioSciences, Inc. | Director | Restricted Stock Units | 0 | 16 Feb 2023 | Direct |